Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

Fortune

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

This J&J exec sold Tylenol and Listerine. Now she runs its $27B medtech business

Ashley McEvoy pivoted from over-the-counter products to medical devices.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

The Independent UK

CDC recommends new COVID boosters

The virus sometimes causes severe illness even in those without underlying conditions, including deaths in children

Salon

Fake Sudafed Is Bullshit, Just As You Suspected

Legal restrictions on pseudoephedrine have not reduced meth use, but they have driven people with colds or allergies toward substitutes that seem to be completely ineffective.

Reason

When and where can you get the updated COVID booster? And who needs one? What you need to know, according to experts

All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Moderna's COVID shots will grow revenue by $8 billion this year. But the company's CFO has his eye on other targets

Moderna plans on investing $25 billion in research and development from 2024 through 2028.

Fortune

‘An epidemic’: Syphilis rages through Texas, causing newborn cases to climb amid treatment shortage

Syphilis rates in Texas continue to climb, alarming healthcare workers who see the highest increases among pregnant people and newborns. A shortage of treatment is complicating efforts to combat it.

The Texas Tribune

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

The Conversation

CDC OKs updated COVID-19 vaccine, clearing way for shots to begin this week

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.

Chicago Sun-Times

CDC panel recommends updated COVID vaccines. Shots could be ready this week

Americans may soon be able to get an updated COVID-19 vaccine

The Independent UK

The CDC has approved updated XBB-strain COVID boosters for all Americans ages 6 months and older. They're expected to hit clinics later this week

The CDC anticipates having adequate supply and shouldn’t need to prioritize certain groups, like the elderly or immunocompromised, for first doses, officials said at a Tuesday committee meeting.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Guardian - US

FDA approves new Covid boosters as cases rise around US

Moderna and Pfizer shots approved with vaccinations potentially beginning as soon as this week

The Independent UK

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise – latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

New Covid boosters approved as CDC set to decide who should receive them amid rising cases

Health officials say that the Pfizer and Moderna shots likely to be available later this week

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

US approves updated COVID vaccines to rev up protection this fall

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

WEKU

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

Chicago Sun-Times

What you should know about new COVID shots

Updated COVID-19 shots will be part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic.”

Roll Call

FDA greenlights new COVID-19 shots for this fall - Roll Call

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.

The Independent UK

Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses

Updated COVID-19 shots are coming soon, part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic."

Al Jazeera

South Africa ‘held to ransom’ by big pharma, overcharged for COVID vaccines

J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal.

The Conversation

FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

320 stories

KFF Health News

239 stories

the Centers for Disease Control and Prevention

237 stories

the Food and Drug Administration

The National Institutes of Health

165 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.